Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

769
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
769
Pulmonary Ventilation: Inhalation01:24

Pulmonary Ventilation: Inhalation

7.8K
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
7.8K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

1.1K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Chronic Pharyngitis01:23

Chronic Pharyngitis

11.5K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
11.5K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

688
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
688

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.

Respiratory medicine·2017
Same author

[Daily care of patients with asthma in the pulmonary practice: changes in asthma - control and therapy depending on the initial level of control].

Pneumologie (Stuttgart, Germany)·2015
Same author

Outbreak of skin and soft tissue infections in a hospital newborn nursery in Italy due to community-acquired meticillin-resistant Staphylococcus aureus USA300 clone.

The Journal of hospital infection·2012
Same author

Relevance of the light line in planar photonic crystal waveguides with weak vertical confinement.

Optics express·2011
Same author

Core-shell La(1-x)Sr(x)MnO3 nanoparticles as colloidal mediators for magnetic fluid hyperthermia.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2010
Same author

[Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].

Deutsche medizinische Wochenschrift (1946)·2009

Related Experiment Video

Updated: Jan 25, 2026

Author Spotlight: Enhancing Grasping Abilities for Hemiplegic Patients with Flexible Robotic Limbs
03:55

Author Spotlight: Enhancing Grasping Abilities for Hemiplegic Patients with Flexible Robotic Limbs

Published on: October 27, 2023

2.8K

[Inhalative immunostimulation in patients with chronic bronchitis].

P Kaspar1, W Petro

  • 1Klinik Bad Reichenhall der LVA Niederbayern/Oberpfalz, Fachklinik für Erkrankungen der Atmungsorgane.

Zeitschrift Fur Hautkrankheiten
|January 1, 1988
PubMed
Summary

This study investigated the effects of polyvalent bacterial lysate (IRS 19) on chronic bronchitis. IRS 19 showed improved bronchoscopic findings and reduced IgG in BAL fluid, suggesting a potential benefit for patients.

More Related Videos

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Related Experiment Videos

Last Updated: Jan 25, 2026

Author Spotlight: Enhancing Grasping Abilities for Hemiplegic Patients with Flexible Robotic Limbs
03:55

Author Spotlight: Enhancing Grasping Abilities for Hemiplegic Patients with Flexible Robotic Limbs

Published on: October 27, 2023

2.8K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

7.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Area of Science:

  • Pulmonology
  • Immunology
  • Microbiology

Background:

  • Chronic bronchitis is a significant respiratory condition characterized by persistent inflammation and mucus production.
  • Current treatments aim to manage symptoms and reduce exacerbations, but novel therapeutic approaches are needed.
  • Bacterial lysates are explored for their potential to modulate immune responses in respiratory infections.

Purpose of the Study:

  • To evaluate the efficacy of inhalative polyvalent bacterial lysate (IRS 19) in patients with chronic bronchitis.
  • To assess the impact of IRS 19 on bronchoscopic findings and bronchial hyperreactivity.
  • To investigate changes in bronchoalveolar lavage (BAL) fluid parameters, including immunoglobulin G (IgG).

Main Methods:

  • A double-blind, placebo-controlled study involving 80 patients with chronic bronchitis.
  • Patients received either IRS 19 or placebo via inhalation for three weeks.
  • Bronchoscopic findings, bronchial hyperreactivity, and BAL fluid composition were assessed.

Main Results:

  • Treatment with IRS 19 led to improved bronchoscopic findings compared to baseline.
  • A modest improvement in bronchial hyperreactivity was observed in the IRS 19 group.
  • Significant reduction in IgG content within BAL fluid was noted in the IRS 19 group; other parameters remained unchanged.

Conclusions:

  • Inhalative IRS 19 demonstrated potential benefits in improving bronchoscopic outcomes for chronic bronchitis patients.
  • IRS 19 may modulate local immune responses, as indicated by reduced IgG levels in BAL fluid.
  • Further research is warranted to explore the therapeutic role of IRS 19 in chronic bronchitis management.